Samuraciclib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSamuraciclib
Drug Alias NamePPDA-001ICEC-0942CT-7001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesMexico +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesCarrick Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A